Browse >
Home / Archive: January 2008
Merck extends its Emend line with a new intravenous form
Written by Drug Topics - Drug Information · Filed Under Drug Topics
Drug Enforcement Administration proposes placing indiplon in Schedule IV
Written by Drug Topics - Drug Information · Filed Under Drug Topics
Survey finds a low drug compliance rate among schizophrenic patients
Written by Drug Topics - Drug Information · Filed Under Drug Topics
This story originally aired in December 2006. In this special edition of FDA PSN, we are repeating some of the most important safety issues that continue to pose a public health concern.
The Institute for Safe Medication Practices recently warned...
Written by Food and Drug Adminstration (FDA): Patient Safety News · Filed Under FDA: News/Recalls
This story originally aired in February 2007. In this special edition of FDA PSN, we are repeating some of the most important safety issues that continue to pose a public health concern.
A recent FDA article in Nursing2006 describes second and th...
Written by Food and Drug Adminstration (FDA): Patient Safety News · Filed Under FDA: News/Recalls
This story originally aired in February 2007. In this special edition of FDA PSN, we are repeating some of the most important safety issues that continue to pose a public health concern.
FDA has issued a Public Health Advisory cautioning practiti...
Written by Food and Drug Adminstration (FDA): Patient Safety News · Filed Under FDA: News/Recalls
This story originally aired in April 2007. In this special edition of FDA PSN, we are repeating some of the most important safety issues that continue to pose a public health concern.
Pneumatic tourniquet systems are used to compress the patient'...
Written by Food and Drug Adminstration (FDA): Patient Safety News · Filed Under FDA: News/Recalls
This story originally aired in September 2007. In this special edition of FDA PSN, we are repeating some of the most important safety issues that continue to pose a public health concern.
FDA has previously warned about the risks of buying drugs ...
Written by Food and Drug Adminstration (FDA): Patient Safety News · Filed Under FDA: News/Recalls
The U.S. Food and Drug Administration today issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions.
Written by Food and Drug Administration Press Releases · Filed Under FDA: News/Recalls
Products were recalled because of the presence of bacteria and particulate matter.
Next Page »